These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38452580)

  • 1. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
    Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
    Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy.
    Maeda K; Uehara T; Hosoda W; Kuraishi Y; Ota H
    Pathol Res Pract; 2024 Oct; 262():155537. PubMed ID: 39178509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
    Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
    Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH17+/CDX2+ Can be Helpful in Providing Support for Small Intestinal Origin Versus Pancreatic or Biliary Origin.
    Ma H; Xiao W; Wang M; Shi X
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):541-545. PubMed ID: 33958523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
    Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H
    Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
    Altree-Tacha D; Tyrrell J; Haas T
    Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
    Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
    Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RGD motif present in cadherin 17 induces integrin activation and tumor growth.
    Bartolomé RA; Peláez-García A; Gomez I; Torres S; Fernandez-Aceñero MJ; Escudero-Paniagua B; Imbaud JI; Casal JI
    J Biol Chem; 2014 Dec; 289(50):34801-14. PubMed ID: 25336636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cadherin 17 in well-differentiated neuroendocrine tumours.
    Snow AN; Mangray S; Lu S; Clubwala R; Li J; Resnick MB; Yakirevich E
    Histopathology; 2015 Jun; 66(7):1010-21. PubMed ID: 25388236
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Akiba H; Iwanari H; Kusano-Arai O; Tsumoto K; Momose T; Hamakubo T; Higashi T
    Ann Nucl Med; 2020 Jan; 34(1):13-23. PubMed ID: 31605356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
    Su MC; Yuan RH; Lin CY; Jeng YM
    Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP; Yu YH; Sheng C; Wang SH
    Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis.
    Bartolomé RA; Barderas R; Torres S; Fernandez-Aceñero MJ; Mendes M; García-Foncillas J; Lopez-Lucendo M; Casal JI
    Oncogene; 2014 Mar; 33(13):1658-69. PubMed ID: 23604127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype.
    Bartolomé RA; Pintado-Berninches L; Martín-Regalado Á; Robles J; Calvo-López T; Ortega-Zapero M; Llorente-Sáez C; Boukich I; Fernandez-Aceñero MJ; Casal JI
    J Exp Clin Cancer Res; 2024 Jan; 43(1):31. PubMed ID: 38263178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors.
    Dwertmann Rico S; Schliesser SJA; Gorbokon N; Dum D; Menz A; Büscheck F; Hinsch A; Lennartz M; von Bargen C; Bawahab AA; Luebke AM; Hube-Magg C; Fraune C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Hoeflmayer D; Krech T; Bernreuther C
    Pathol Int; 2023 Jul; 73(7):281-296. PubMed ID: 37057870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.
    Matsusaka K; Ushiku T; Urabe M; Fukuyo M; Abe H; Ishikawa S; Seto Y; Aburatani H; Hamakubo T; Kaneda A; Fukayama M
    Oncotarget; 2016 Sep; 7(39):64168-64181. PubMed ID: 27580354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors.
    Lutz F; Han SY; Büyücek S; Möller K; Viehweger F; Schlichter R; Menz A; Luebke AM; Bawahab AA; Reiswich V; Kluth M; Hube-Magg C; Hinsch A; Weidemann S; Lennartz M; Dum D; Bernreuther C; Lebok P; Sauter G; Marx AH; Simon R; Krech T; Fraune C; Gorbokon N; Burandt E; Minner S; Steurer S; Clauditz TS; Jacobsen F
    Diagnostics (Basel); 2024 Sep; 14(19):. PubMed ID: 39410561
    [No Abstract]   [Full Text] [Related]  

  • 20. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
    Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
    Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.